Perfusion Loop Assembly for an Ex-Vivo Liver Perfusion and a Method for Ex-Vivo Liver Perfusion

Patent metadata

Field	Value
Publication number	US-2025151715-A1
Application number	US-202519024382-A
Country	US
Kind code	A1
Filing date	Jan 16, 2025
Priority date	Jan 19, 2018
Publication date	May 15, 2025
Grant date	—

Abstract

A perfusion loop assembly for ex vivo liver perfusion includes a pump providing perfusion fluid through a line branching at a branching point into a first branch line and a second branch line. The first branch line provides a first portion of the perfusion fluid to the hepatic artery of the liver, the first branch line coupled with a gas exchanger, where the first branch line includes a flow rate sensor and/or a pressure sensor. The second branch line provides a second portion of the perfusion fluid to the portal vein of the liver; the second branch line includes a valve for controlling flow of perfusion fluid into the portal vein. The second branch line includes a flow rate sensor and/or a pressure sensor. A liver chamber assembly holds the liver ex vivo, and an outlet line for the perfusion fluid connects the liver chamber assembly and the pump.

First claim

1 . A method for profusion of an ex vivo liver using a perfusion loop assembly that comprises:
a pump and a line, wherein the pump is configured to provide a fluid flow of a perfusion fluid through the line and wherein the line branches at a branching point into a first branch line and a second branch line downstream of the pump; the first branch line being configured to provide a first portion of the perfusion fluid to the hepatic artery (arteria hepatica propria or arteria hepatica communis) of the ex vivo liver; the first branch line being coupled with a gas exchanger, wherein the first branch line comprises a port for administering additives to the perfusion fluid in the first branch line; wherein the first branch line comprises a flow rate sensor and a pressure sensor, the second branch line being configured to provide a second portion of the perfusion fluid to the portal vein (vena portae hepatis) of the ex vivo liver; the second branch line further comprising a first valve for controlling the flow of the perfusion fluid into the portal vein of the ex vivo liver, wherein the second branch line comprises a port for administering additives to the perfusion fluid in the second branch line; wherein the second branch line comprises a flow rate sensor and a pressure sensor; a liver chamber assembly configured to hold the ex vivo liver, a liver outlet line configured to be attached to the vena cava (vena cava inferior) of the ex vivo liver, the liver outlet line further comprising a second valve for adjusting the pressure in the outlet line at the vena cava of the ex vivo liver, wherein the outlet line comprises a pressure sensor, a reservoir connected to the liver outlet line and upstream from the pump, a bypass between the first branch line and the second branch line, wherein the bypass connects the first branch line downstream of the gas exchanger with the second branch line downstream of the first valve, or a bypass between the first branch line and the reservoir, and a dialysis machine for adjusting the composition of the perfusion fluid, wherein the dialysis machine is implemented between the liver outlet line upstream of the reservoir and the second branch line, wherein the method comprises adjusting, by the second valve, the pressure in the liver outlet line such that physiological pressure values and variations are generated.

2 . The method according to claim 1 , wherein a pulsatile flow is induced in the first branch line (hepatic artery line) by a pulsatile operation of the pump.

3 . The method according to claim 1 , wherein a targeted mean pressure in the first branch line is adjusted by administering vasodilators and vasoconstrictors into the first branch line through the port for administering additives in the first branch line.

4 . The method according to claim 1 , wherein the perfusion medium undergoes dialysis during ex vivo perfusion for correcting electrolytes, removing waste products, and for maintaining the hematocrit level in the perfusion fluid in the physiological range.

5 . The method according to claim 1 , wherein blood gases are monitored by at least one of the sensors, and wherein the oxygen saturation SO 2 , hemoglobin and hematocrit value in the perfusion fluid in the outlet line are monitored by a sensor.

6 . The method according to claim 1 , wherein the glucose level in the perfusate is measured online by a glucose sensor and the glucose level is regulated by automatically administering insulin and/or glucagon.

7 . The method according to claim 1 , wherein the pressure variations are between −10 and 12 mmHG.

8 . The method according to claim 1 , wherein the pressure variations are between −5 and 10 mmHG.

9 . The method according to claim 1 , wherein the pressure variations are between 0 and 3 mmHG.

10 . The method according to claim 1 , wherein the blood gases comprise at least one of the following: pCO2, pO2, other components in the perfusion fluid, or any combination thereof.

11 . The method according to claim 10 , wherein the blood gases comprise potassium.

12 . The method according to claim 10 , wherein the blood gases in the first branch line and the second branch line are monitored by at least one of the sensors.

Assignees

• Eth Zuerich
• Univ Zuerich

Inventors

• Becker Dustin
• Eshmuminov Dilmurodjon
• Hefti Max Leo
• Schuler Martin Jörg
• Rudolf Von Rohr Philipp
• Clavien Pierre-Alain
• Graf Rolf
• Bautista Borrego Lucia
• Muller Xavier
• Dutkowski Philipp

Classifications

• A01N1/126

  Physiologically active agents, e.g. antioxidants or nutrients · CPC title

• A01N1/124

  Disinfecting agents, e.g. antimicrobials · CPC title

• A01N1/143 Primary

  for organ perfusion · CPC title